Co-Diagnostics, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Co-Diagnostics, Inc. (CODX) reported Cash and Cash Equivalents, Period Increase (Decrease) of $4.46 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-14.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-05-14
- Co-Diagnostics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was $4.46M.
- Co-Diagnostics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$1.23M.
- Co-Diagnostics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was $648.30K, a 85.62% decline year-over-year.
- Co-Diagnostics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was -$1.01M.
- Co-Diagnostics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$2.58M, a 201.91% decline from fiscal 2017.
- Co-Diagnostics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $2.54M, a 162.79% increase from fiscal 2016.
- Co-Diagnostics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $964.93K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2019-03-31 | $4.46M 10-Q · filed 2019-05-14 | $3.24M derived: sum of 2 quarters · filed 2019-05-14 | $3.88M derived: sum of 3 quarters · filed 2019-05-14 | $2.87M derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-12-31 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$578.03K derived: sum of 2 quarters · filed 2019-04-01 | -$1.59M derived: sum of 3 quarters · filed 2019-04-01 | -$2.58M 10-K · filed 2019-04-01 |
| 2018-09-30 | $648.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$364.68K derived: sum of 2 quarters · filed 2018-11-14 | -$1.36M 10-Q · filed 2018-11-14 | -$2.45M derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-06-30 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$2.01M 10-Q · filed 2018-08-10 | -$3.10M derived: sum of 3 quarters · filed 2019-05-14 | $1.41M derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-03-31 | -$993.21K 10-Q · filed 2019-05-14 | -$2.08M derived: sum of 2 quarters · filed 2019-05-14 | $2.42M derived: sum of 3 quarters · filed 2019-05-14 | $2.04M derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | -$1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $3.42M derived: sum of 2 quarters · filed 2019-04-01 | $3.04M derived: sum of 3 quarters · filed 2019-04-01 | $2.54M 10-K · filed 2019-04-01 |
| 2017-09-30 | $4.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $4.13M derived: sum of 2 quarters · filed 2018-11-14 | $3.63M 10-Q · filed 2018-11-14 | $4.57M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | -$379.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$881.96K 10-Q · filed 2018-08-10 | $63.40K derived: sum of 3 quarters · filed 2018-08-10 | $115.30K derived: sum of 4 quarters · filed 2018-08-10 |
| 2017-03-31 | -$502.28K 10-Q · filed 2018-05-14 | $443.08K derived: sum of 2 quarters · filed 2018-05-14 | $494.98K derived: sum of 3 quarters · filed 2018-05-14 | |
| 2016-12-31 | $945.36K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $997.26K derived: sum of 2 quarters · filed 2018-03-28 | $964.93K 10-K · filed 2018-03-28 | |
| 2016-09-30 | $51.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $19.57K 10-Q · filed 2017-11-14 | ||
| 2016-06-30 | -$32.33K 10-Q · filed 2017-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |